Clinical Trials Browser

Hypereosinophilic Syndrome × ruxolitinib × 90 days × Clear all

NCT00044304 2026-03-16

Tyrosine Kinase Inhibition to Treat Myeloid Hypereosinophilic Syndrome

Phase 2 Active not recruiting

Hypereosinophilic Syndrome